Nicholas F. Munaretto
LAS VEGAS — Use of radiotherapy in patients with soft tissue sarcoma of the hand was not associated with worse functional outcomes compared with patients who did not receive radiotherapy, according to results presented here.
Nicholas F. Munaretto , MD, and colleagues assessed Musculoskeletal Tumor Society 93 (MSTS93) and QuickDASH scores for 46 patients with soft tissue sarcoma of the hand and determined whether they had any tumor recurrence or further operative interventions.
“The 10-year local recurrence-free survival in our cohort was 84%, and there was no difference in local recurrence between patients with and without radiotherapy,” Munaretto said in his presentation at the American Society for Surgery of the Hand Annual Meeting.
Of the 33 patients contacted for full follow-up, Munaretto noted 22 patients completed the MSTS93 and QuickDASH scores. Patients had a mean QuickDASH score of about 7 and a mean MSTS93 score of about 92%, according to Munaretto.
“When comparing patients who received or did not receive radiotherapy, there was no significant difference between the mean QuickDASH or MSTS93 scores,” Munaretto said.
Although 33% of patients who received radiotherapy experienced surgical complications vs. 17% of patients who did not receive radiotherapy, Munaretto noted this was not statistically significant.
“Complications associated with the radiotherapy included soft tissue contracture in four patients, fibrosis leading to carpal tunnel syndrome in one patient and skin necrosis in one patient,” Munaretto said. – by Casey Tingle
Munaretto NF, et al. Abstract 29. Presented at: American Society for Surgery of the Hand Annual Meeting; Sept. 5-7, 2019; Las Vegas.
Disclosure: Munaretto reports no relevant financial disclosures.